“Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide.”
The global syphilis testing market to reach $3.6 billion by 2020. The secondary syphilis testing would continue to be the largest market segment through 2020. Latin America, Middle East & Africa (LAMEA) market accounted for about 43% revenue share of the global syphilis testing market in 2014.
Rising Syphilis cases remain a vital public health issue and is a significant concern across the globe, especially in developing economies. Rising burden of syphilis incidences and implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide. Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy and Microhemagglutination (MHA-TP) assay enables faster and improved screening results – thus provides additional boost to the market growth. However, social stigma associated with patients visiting to STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/675
LAMEA and Asia Pacific constitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions.
The major players in the syphilis testing market space are focusing on technological advancements, product & service innovation in order to retain their position in the market. Major companies profiled in the report include Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories, BioMerieux, Alere Inc., Cepheid Inc., Affymetrix, Inc. and Diasorin.
Key findings of the study:
- LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period
- United states remains a major market in North America syphilis testing market through 2020
- Spain and Germany collectively accounts for about one fourth of the Europe syphilis testing market
- China and India collectively accounts for about 89% share in the Asia Pacific syphilis testing market
For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/675
Scope of the Report:
|Market size available for years||2015-2020|
|Base year considered||2015|
|Forecast units||Value (USD)|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
Cardiac Biomarkers Testing Market by Type (Myocardial Muscle Creatine Kinase, Troponins, Myoglobin, Brain Natriuretic Peptide, Ischemia-modified Albumin, and Others), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others) and Location of Testing (Point of care Testing and Laboratory Testing): Global Opportunity Analysis and Industry Forecast, 2019–2026
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht